Modified AutoDock for accurate docking of protein kinase inhibitors

被引:51
作者
Buzko, OV [1 ]
Bishop, AC [1 ]
Shokat, KM [1 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
关键词
approximation of solvation; AutoDock; force field; hydrogen bonding; inhibitor design; scoring function;
D O I
10.1023/A:1016366013656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases are an important class of enzymes controlling virtually all cellular signaling pathways. Consequently, selective inhibitors of protein kinases have attracted significant interest as potential new drugs for many diseases. Computational methods, including molecular docking, have increasingly been used in the inhibitor design process [1]. We have considered several docking packages in order to strengthen our kinase inhibitor work with computational capabilities. In our experience, AutoDock offered a reasonable combination of accuracy and speed, as opposed to methods that specialize either in fast database searches or detailed and computationally intensive calculations. However, AutoDock did not perform well in cases where extensive hydrophobic contacts were involved, such as docking of SB203580 to its target protein kinase p38. Another shortcoming was a hydrogen bonding energy function, which underestimated the attraction component and, thus, did not allow for sufficiently accurate modeling of the key hydrogen bonds in the kinase-inhibitor complexes. We have modified the parameter set used to model hydrogen bonds, which increased the accuracy of AutoDock and appeared to be generally applicable to many kinase-inhibitor pairs without customization. Binding to largely hydrophobic sites, such as the active site of p38, was significantly improved by introducing a correction factor selectively affecting only carbon and hydrogen energy grids, thus, providing an effective, although approximate, treatment of solvation.
引用
收藏
页码:113 / 127
页数:15
相关论文
共 63 条
[41]   VANDERWAALS VOLUME FRAGMENTAL CONSTANTS [J].
MOTOC, I ;
MARSHALL, GR .
CHEMICAL PHYSICS LETTERS, 1985, 116 (05) :415-419
[42]   Small Molecule Docking and Scoring [J].
Muegge, Ingo ;
Rarey, Matthias .
REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 17, 2001, 17 :1-60
[43]   Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation [J].
Okamoto, S ;
Krainc, D ;
Sherman, K ;
Lipton, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7561-7566
[44]   Receptor-based prediction of binding affinities [J].
Oprea, TI ;
Marshall, GR .
PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1998, 9-11 :35-61
[45]   QUANTUM-MECHANICAL MODEL ASSEMBLY STUDY ON THE ENERGETICS OF BINDING OF ARABINOSE, FUCOSE, AND GALACTOSE TO L-ARABINOSE-BINDING PROTEIN [J].
PERAKYLA, M ;
PAKKANEN, TA .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1994, 20 (04) :367-372
[46]   Signaling pathways in insulin action: molecular targets of insulin resistance [J].
Pessin, JE ;
Saltiel, AR .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) :165-169
[47]   Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? [J].
Reuter, CWM ;
Morgan, MA ;
Bergmann, L .
BLOOD, 2000, 96 (05) :1655-1669
[48]   SOLVATION EFFECTS [J].
RICHARDS, WG ;
KING, PM ;
REYNOLDS, CA .
PROTEIN ENGINEERING, 1989, 2 (05) :319-327
[49]   Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor [J].
Schindler, T ;
Sicheri, F ;
Pico, A ;
Gazit, A ;
Levitzki, A ;
Kuriyan, J .
MOLECULAR CELL, 1999, 3 (05) :639-648
[50]   High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: Bound waters and natural ligand as guides for inhibitor design [J].
SchulzeGahmen, U ;
DeBondt, HL ;
Kim, SH .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) :4540-4546